Insight Genetics And Vanderbilt-Ingram Cancer Center Partner To Improve Breast Cancer Diagnosis And Treatment

NASHVILLE, Tenn.--(BUSINESS WIRE)--Insight Genetics, Inc. is collaborating with Vanderbilt-Ingram Cancer Center (VICC) to enhance how researchers and oncologists classify and treat patients diagnosed with triple-negative breast cancer (TNBC). The molecular diagnostics company is working with VICC scientists to identify genetic markers that will help select the targeted therapeutics most effective for each individual TNBC patient.

Help employers find you! Check out all the jobs and post your resume.